Brezden-Masley, Christine
Fathers, Kelly E.
Coombes, Megan E.
Pourmirza, Behin
Xue, Cloris
Jerzak, Katarzyna J. http://orcid.org/0000-0002-3995-0308
Funding for this research was provided by:
F. Hoffmann-La Roche
Article History
Received: 10 July 2020
Accepted: 8 October 2020
First Online: 22 October 2020
Compliance with ethical standards
:
: CBM has served as a consultant/speaker/advisory board attendee for: Novartis, Hoffmann-La Roche, Eli Lilly, Amgen, Pfizer, Astra Zeneca, Genomic Health, Merck, Taiho, Myriad, Apobiologix, and Mylan. MEC, KEF, BP, and CX are employees of Hoffmann-La Roche Ltd. KJJ has served as a consultant/speaker/advisory board attendee for Apobiologix, Esai, Genomic Health, Novartis, Pfizer, Purdue Pharma, and Hoffmann-La Roche. She also received research support from Astra Zeneca and Eli Lilly.
: Approval was obtained from the ethics committee of the Ontario Cancer Research Ethics Board. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.